Navigation Links
Changes needed for oft-ignored prescription warning labels
Date:6/29/2012

EAST LANSING, Mich. Each year, an estimated four million Americans experience adverse reactions to prescription medications. Many of these reactions, ranging from mild rashes and drowsiness to hospitalization and death, could be avoided if warning labels were more effective, according to a Michigan State University study.

When patients are handed a new prescription, few read the critical warning labels such as "do not consume alcohol while taking this medication" or "for external use only." Using eye-tracking technology, MSU researchers found that one source of the labels' ineffectiveness is an inability to capture patients' attention.

The study, which appears in the current issue of PLoS ONE, reveals that only 50 percent of participants looked directly at the warning labels, and 22 percent did not look at any. Laura Bix, associate professor in MSU's School of Packaging, suggests that relatively simple changes could improve the labels' effectiveness.

"Given our results, we are recommending a complete overhaul of the design and labeling of the ubiquitous amber bottles, which have seen little change since their introduction some 50 years ago," Bix said. "Our initial recommendations would be to move all of the warnings from the colored stickers to the main, white label, which 100 percent of the participants read, or to reposition the warnings so that they can be seen from this vantage point."

The impact of this study could be especially beneficial to older patients. On average, more than 30 percent of those 65 and older take 10 different medications daily. Taking multiple medications increases the odds of adverse reactions. This combination is complicated further since older participants were less likely to notice or remember warning labels. Not surprisingly, more people who saw the stickers could recall them better, suggesting that enhancing the labels' noticeability is a key factor for people remembering the warnings.

The results highlight the importance of how labels influence the attention process, said Mark Becker, assistant professor of cognition and cognitive neuroscience.

"By applying basic research on the control of attention to the design of labels, we may greatly improve their effectiveness," he said. "This collaboration between the School of Packaging and the Department of Psychology makes such efforts possible."

Bix and other MSU researchers have plans to continue testing the effectiveness of new and existing prescription packaging as well as reviewing prescription drug leaflets, currently under regulatory debate.


'/>"/>
Contact: Layne Cameron
layne.cameron@cabs.msu.edu
517-353-8819
Michigan State University
Source:Eurekalert  

Related medicine news :

1. States' Next Steps on Health Reform - Will They Launch Exchanges?
2. Productivity gains from health IT must await bigger health system changes
3. Psychoeducational intervention changes patient attitudes on clinical trials participation
4. Mindful Meditation Tied to Healthy Brain Changes: Study
5. Lung changes are present in nearly half of ACPA positive RA patients at disease onset
6. VCU researchers identify changes in cholesterol metabolic pathways
7. First study to suggest that the immune system may protect against Alzheimers changes in humans
8. Tiny Tots in the Dentists Chair Among Changes in Pediatric Dentistry
9. From One Generation to the Next, Dental Care Changes
10. Eye Changes May Predict Heart Disease in Blacks With Diabetes
11. Chronic cocaine use triggers changes in brains neuron structure
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Changes needed for oft-ignored prescription warning labels
(Date:3/27/2017)... ... March 27, 2017 , ... M&S ... Certificate of Conformity for the Smart System® 20/20. CE Certification builds upon M&S's ... standards and specifications such as ANSI, ISO and proven test methods used in ...
(Date:3/27/2017)... PA (PRWEB) , ... March 27, 2017 , ... ... business simulation -centric training, today announced the launch of a new research ... strategy, having the skills needed to execute that strategy, and the actual success ...
(Date:3/27/2017)... ... March 27, 2017 , ... According to the American Cancer ... stages, is more than 95%. Once the cancer spreads to other organs, bones, or ... find out how to avoid this latter group, tune in to Lifestyle Magazine ...
(Date:3/27/2017)... Texas (PRWEB) , ... March 27, 2017 , ... ... at the GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to commemorate ... and will be an opportunity for area-residents to celebrate two great years while ...
(Date:3/25/2017)... PA (PRWEB) , ... March 25, 2017 , ... Getting ... as a public relations partner. , All through the year, Garden Media aims ... press releases, working with key influencers and pitching client’s key messages to ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immunotherapy successfully passed early toxicology and efficacy studies. The ... to target a specific protein, MAGE A, in an ... breast cancer. After 4 weeks of ... to show very little toxicity in a full toxicology ...
(Date:3/27/2017)... , March 27, 2017  Sanderling Ventures, portfolio ... Ethicon, a division of Johnson & Johnson. Torax manufactures ... the treatment of gastro-esophageal reflux disease (GERD). The ... (MSA) technology and the procedure is currently available ... Torax Medical was founded by Sanderling Ventures, ...
(Date:3/27/2017)... TEL AVIV, Israel , March 27, 2017 ... focused on oncology and immunology, announced today that AGI-134, an ... recently announced acquisition of Agalimmune Ltd., will be featured at ... Meeting in Washington, DC to ... ...
Breaking Medicine Technology: